Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
Pfizer Raises 2021 Outlook On Surging COVID-19 Vaccine Sales – Channels Television
From Pfizer to Moderna: who's making billions from Covid-19 vaccines? | Pharmaceuticals industry | The Guardian
Gesundheit: Biontech-Chef: Haben noch harte Monate vor uns | ZEIT ONLINE
5 things about BioNTech and the couple behind the COVID-19 vaccine with Pfizer - MarketWatch
Inequality.org - $2 billion: The net-worth gain for the three top shareholders in BioNTech, Pfizer's partner on Covid vaccine development. Moderna, Pfizer's Covid vaccine development rival, has so far this year minted
Biontech-CFO Sierk Poetting ist CFO des Monats
BioNTech - Wikipedia
Chart: Pfizer Revenue Boosted by Covid-19 Drugs | Statista
BioNTech: A Small German Biotech Company Hopes to Make the Leap to Global Player - DER SPIEGEL
BioNTech profile: Firm working with Pfizer for COVID-19 vaccine
BioNTech's co-founder now among 500 richest people, Health News, ET HealthWorld
Holger Zschaepitz on Twitter: "#BionTech Founder Ugur Sahin just reached another milestone: He joined the world's 500 richest people w/net worth of ~$5bn. He is the 34th wealthiest man in #Germany after
Uğur Şahin - Wikipedia
BioNTech CEO Uğur Şahin featured on Bloomberg's latest billionaires list | Ahval
BioNTech's second act: can it transform the fight against cancer? | Financial Times
Chart: How COVID-19 Vaccines Changed Pharma Company Profits | Statista
5 things about BioNTech and the couple behind the COVID-19 vaccine with Pfizer - MarketWatch
The CEO of Pfizer on Developing a Vaccine in Record Time
BioNTech Founder Ugur Sahin Now Among World's Richest After UK Clears Vaccine
How a Coronavirus Vaccine Maker's Stock Went From Dud to Star - WSJ
Covid vaccine profits mint 9 new pharma billionaires | CNN Business
